The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Dexamethasone in Hospitalized Patients with Covid-19
Open accessPublished version of a preprint
Abstract
BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. METHODS: In this controlled, open-label trial comparing a range of possible treatments in patients who were hospitalized with Covid-19, we randomly assigned patients to receive oral or intravenous dexamethasone (at a dose of 6 mg once daily) for up to 10 days or to receive usual care alone. The primary outcome was 28-day mortality. Here, we report the final results of this assessment. RESULTS: A total of 2104 patients were assigned to receive dexamethasone and 4321 to receive usual care. Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died within 28 days after randomization (age-adjusted rate ratio, 0.83; 95% confidence interval [CI], 0.75 to 0.93; P<0.001). The proportional and absolute between-group differences in mortality varied considerably according to the level of respiratory support that the patients were receiving at the time of randomization. In the dexamethasone group, the incidence of death was lower than that in the usual care group among patients receiving invasive mechanical ventilation (29.3% vs. 41.4%; rate ratio, 0.64; 95% CI, 0.51 to 0.81) and among those receiving oxygen without invasive mechanical ventilation (23.3% vs. 26.2%; rate ratio, 0.82; 95% CI, 0.72 to 0.94) but not among those who were receiving no respiratory support at randomization (17.8% vs. 14.0%; rate ratio, 1.19; 95% CI, 0.92 to 1.55). CONCLUSIONS: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support. (Funded by the Medical Research Council and National Institute for Health Research and others; RECOVERY ClinicalTrials.gov number, NCT04381936; ISRCTN number, 50189673.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until the release of the RECOVERY trial,66 patients with severe COVID-19 were not routinely treated with GC agonists such as dexamethasone.”
From Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, dexamethasone reduces the death rate of patients with severe COVID-19 (370).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [370]
In the citing paper
“These studies were, however, restricted to only publications up to August and October 2020—which is not representative of the current landscape of covid-19 research and which does not include the majority of evidence being currently used to guide covid-19 care, including critical trials of the effects of corticosteroids and interleukin 6 receptor blockers.”
From Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review (2022) · cites this paper as [2]
In the citing paper
“reports of hemophagocytosis and elevated cytokine levels — as well as beneficial effects of immunosuppressant agents — in affected patients, particularly those who are the most severely ill, suggest that cytokine storm may contribute to the pathogenesis of Covid-19.87,88”
From Cytokine storm (2020) · cites this paper as [88]
In the citing paper
“a recent randomized, controlled trial showing that dexamethasone reduces mortality among the most severe cases of Covid-19, characterized by elevated CRP levels and supplemental oxygen requirements, and potentially worsens outcomes in milder cases suggests that excessive, late-stage inflammation contributes to mortality.88”
From Cytokine storm (2020) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Research works printed but not linked: 2
- Corral-Gudino L Bahamonde A Arnaiz-Revillas F et al. GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia. June 18 2020 (https://www.medrxiv.org/content/10.1101/2020.06.17.20133579v1). preprint. · DOI
- Siemieniuk R, Rochwerg B, Agoritsas T, et al. A living WHO guideline on drugs for Covid-19. BMJ 2020;370:m3379-m3379.32887691
Cited by
Sorted by citations
Items 901–1,000 of 1,036
Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
Kumar, D., & Trivedi, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111642 · Cited by 80
Goffin, E. J., Candellier, A., Vart, P., Noordzij, M., Arnol, M., Covic, A. C., Lentini, P. L. M., Malik, S., Reichert, L. J. M., Sever, M. Ş., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab200 · Cited by 79
Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling
Zizzo, G., Tamburello, A., Castelnovo, L., Laria, A., Mumoli, N., Faggioli, P. M., Stefani, I., & Mazzone, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795315 · Cited by 78
Tavares, J., Oliveira, J., Reis, P., Ribeiro, B., Silva, F., Malheiro, J., Almeida, M., Martins, L. S., Cabrita, A., Henriques, A. C., et al. (2022) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2021-0257en · Cited by 83
Boro, E., & Stoll, B. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.928065 · Cited by 86
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection
Navarese, E. P., Podhajski, P., Gurbel, P. A., Grzelakowska, K., Ruscio, E., Tantry, U. S., Magielski, P., Kubica, A., Niezgoda, P., Adamski, P., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.10.030 · Cited by 79
Stotts, C., Corrales‐Medina, V., & Rayner, K. J. (2023) · Circulation Research · doi:10.1161/circresaha.122.321636 · Cited by 89
The Integration of Clinical Trials With the Practice of Medicine
Angus, D. C., Huang, A. J., Lewis, R. J., Abernethy, A. P., Califf, R. M., Landray, M., KASS, N. E., Bibbins-Domingo, K. B., Abbasi, A. B., Abebe, K. Z., et al. (2024) · JAMA · doi:10.1001/jama.2024.4088 · Cited by 91
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19 – Preliminary ReportPreprint
REMAP-CAP, T., ACTIV-4a, ATTACC Investigators, & Zarychanski, R. (2021) · medRxiv · doi:10.1101/2021.03.10.21252749 · Cited by 79
Cardinali, D. P., Brown, G. M., Reiter, R. J., & Pandi-Perumal, S. R. (2020) · Sleep and Vigilance · doi:10.1007/s41782-020-00111-7 · Cited by 79
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19
Needham, E., Newcombe, V., Michell, A. W., Thornton, R., Grainger, A. J., Anwar, F., Warburton, E. A., Menon, D. K., Trivedi, M., & Sawcer, S. J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10321-8 · Cited by 78
The effects of wearing facemasks on oxygenation and ventilation at rest and during physical activity
Shein, S. L., Whitticar, S., Mascho, K., Pace, E., Speicher, R. H., & Deakins, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247414 · Cited by 78
Requião‐Moura, L., de Sandes‐Freitas, T. V., Viana, L. A., Cristelli, M. P., de Andrade, L. G. M., Garcı́a, V. D., de Oliveira, C. M. C., Esmeraldo, R. D. M., Abbud‐Filho, M., Pacheco‐Silva, Á., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254822 · Cited by 78
Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients
Ergün, M., Brüggemann, R. J. M., Alanio, A., Dellière, S., van Arkel, A., Bentvelsen, R. G., Rijpstra, T., der Brugge, S. V. D. S.-V., Lagrou, K., Janssen, N. A. F., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01229-21 · Cited by 78
Mansour, A., Flecher, E. M., Schmidt, M., Rozec, B. R., Gouin‐Thibault, I., Esvan, M., Fougerou, C., Lévy, B., Porto, A., Ross, J. T., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06794-y · Cited by 78
Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients
Remsik, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M., Iacobuzio-Donahue, C. A., Avila, E. K., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.007 · Cited by 77
Severe COVID-19: what have we learned with the immunopathogenesis?
Corrêa, B. B., Rodrigues, M. B., Cortez, A. F., Vieira, M., & Pinheiro, M. M. (2020) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-020-00151-7 · Cited by 83
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
Menzella, F., Fontana, M. S., Salvarani, C., Massari, M., Ruggiero, P., Scelfo, C., Barbieri, C., Castagnetti, C., Catellani, C., Gibellini, G., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03306-6 · Cited by 77
Mosquera-Yuqui, F., Lopez-Guerra, N., & Moncayo, E. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1835716 · Cited by 77
A Systematic Review of COVID-19 and Kidney Transplantation
Mahalingasivam, V., Craik, A., Tomlinson, L. A., Ge, L., Hou, L., Wang, Q., Yang, K., Fogarty, D. G., & Keenan, C. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.10.023 · Cited by 80
Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
Riley, T. R., & George, M. (2021) · RMD Open · doi:10.1136/rmdopen-2020-001235 · Cited by 77
The role of CD71+ erythroid cells in the regulation of the immune response
Grzywa, T. M., Nowis, D., & Gołąb, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107927 · Cited by 81
Role of total lung stress on the progression of early COVID-19 pneumonia
Coppola, S., Chiumello, D., Busana, M., Giola, E., Palermo, P., Pozzi, T., Steinberg, I., Roli, S., Romitti, F., Lazzari, S., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06519-7 · Cited by 77
Schmidt, M., Langouet, E., Hajage, D., James, S. A., Chommeloux, J., Bréchot, N., Barhoum, P., Lefèvre, L., Troger, A., de Chambrun, M. P., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03780-6 · Cited by 77
Zhuravel, S. V., Khmelnitskiy, O., Burlaka, O. O., Gritsan, A. I., Goloshchekin, B. M., Kim, S., & Hong, K. Y. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101169 · Cited by 77
Treatment of MIS-C in Children and Adolescents
Mahmoud, S. A., El-Kalliny, M. M., Kotby, A., El-Ganzoury, M. M., Fouda, E. M., & Ibrahim, H. M. (2022) · Current Pediatrics Reports · doi:10.1007/s40124-021-00259-4 · Cited by 85
Polizzotto, M. N., Nordwall, J. A., Babiker, A. G., Phillips, A., Vock, D. M., Eriobu, N., Kwaghe, V., Paredes, R., Mateu, L., Ramachandruni, S., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00101-5 · Cited by 78
Tan, B. W. L., Tan, B. W. Q., Tan, A. L. M., Schriver, E., Gutiérrez‐Sacristán, A., Das, P., Yuan, W., Hutch, M. R., Barrio, N. G., Pedrera‐Jiménez, M., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101724 · Cited by 77
Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results
Ameri, A., Rahnama, N., Bozorgmehr, R., Mokhtari, M., Farahbakhsh, M., Nabavi, M., Shoaei, . D., Izadi, H., Kashi, A. S. Y., Dehbsneh, H. S., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.07.026 · Cited by 76
COVID-19 Therapeutic Options Under Investigation
Kaddoura, M., Ibrahim, M. A., Hijazi, G., Soudani, N., Audi, A., Alkalamouni, H., Haddad, S., Eid, A. H., & Zaraket, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01196 · Cited by 75
Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives
Mahmud, I., & Garrett, T. J. (2020) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00238 · Cited by 80
Benkeser, D. C., Diaz, I. M., Luedtke, A. R., Segal, J. B., Scharfstein, D. O., & Rosenblum, M. (2020) · Biometrics · doi:10.1111/biom.13377 · Cited by 83
Sarilumab use in severe SARS-CoV-2 pneumonia
Gremese, E., Cingolani, A., Bosello, S. L., Alivernini, S., Tolusso, B., Perniola, S., Landi, F., Pompili, M., Murri, R., Santoliquido, A., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100553 · Cited by 75
Endothelial cells and SARS-CoV-2: An intimate relationship
Barbosa, L. C., Gonçalves, T. L., de Araújo, L. P., Rosário, L., & Ferrer, V. P. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106829 · Cited by 78
Pontali, E., Volpi, S., Signori, A., Antonucci, G., Castellaneta, M., Buzzi, D., Montale, A., Bustaffa, M., Angelelli, A., Caorsi, R., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.024 · Cited by 76
Epithelial Cells and Inflammation in Pulmonary Wound Repair
Lucchini, A. C., Gachanja, N. N., Rossi, A. G., Dorward, D. A., & Lucas, C. D. (2021) · Cells · doi:10.3390/cells10020339 · Cited by 79
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
Aguas, R. J., Mahdi, A., Shretta, R., Horby, P., Landray, M., White, L. J., Arifi, F., Zhumalieva, C., Lubis, I. N. D., Monteiro, A. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21134-2 · Cited by 76
COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies
Calabretta, E., Moraleda, J. M., Iacobelli, M., Jara, R., Vlodavsky, I., O’Gorman, P., Pagliuca, A., Mo, C. C., Baron, R. M., Aghemo, A., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17240 · Cited by 75
Andolfo, I., Russo, R., Lasorsa, V. A., Cantalupo, S., Rosato, B. E., Bonfiglio, F., Frisso, G., Abete, P., Cassese, G. M., Servillo, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102322 · Cited by 77
Snow, T. A. C., Saleem, N., Ambler, G., Nastouli, E., Singer, M., & Arulkumaran, N. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06416-z · Cited by 76
Overview of the pathogenesis of COVID‑19 (Review)
Li, C., He, Q., Qian, H., & Liu, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10444 · Cited by 90
The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework
Gatto, N. M., Campbell, U. B., Rubinstein, E. R., Jaksa, A. A., Mattox, P. W., Mo, J., & Reynolds, R. F. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2466 · Cited by 76
Walz, L., Cohen, A. J., Rebaza, A. P., Vanchieri, J., Slade, M. D., Dela Cruz, C. S., & Sharma, L. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05730-z · Cited by 82
Immunotherapeutic approaches to curtail COVID-19
Owji, H., Negahdaripour, M., & Hajighahramani, N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106924 · Cited by 79
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Sharun, K., Tiwari, R., Dhama, J., & Dhama, K. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.08.038 · Cited by 75
Clinical characteristics and manifestations in older patients with COVID-19
Wei, C., Liu, Y., Liu, Y., Zhang, K., Su, D., Zhong, M., & Xiao, M. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01811-5 · Cited by 75
Catecholamine physiology and its implications in patients with COVID-19
Gubbi, S., Nazari, M. A., Taïeb, D., Kłubo-Gwieździńska, J., & Pacák, K. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30342-9 · Cited by 73
Bain, R., Cosgriff, R., Zampoli, M., Elbert, A., Burgel, P., Carr, S. B., Castaños, C., Colombo, C., Corvol, H., Faro, A., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.11.021 · Cited by 75
Saletti, G., Gerlach, T. H., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-78506-9 · Cited by 74
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
Bartoli, A., Gabrielli, F., Alicandro, T., Nascimbeni, F., & Andreoné, P. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02569-9 · Cited by 74
Rationale for azithromycin in COVID-19: an overview of existing evidence
Gyselinck, I., Janssens, W., Verhamme, P. B., & Vos, R. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000806 · Cited by 74
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area
Verma, A. A., Hora, T., Jung, H. Y., Fralick, M., Malecki, S. L., Lapointe‐Shaw, L., Weinerman, A. S., Tang, T., Kwan, J. L., Liu, J. J., et al. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202795 · Cited by 76
Cellular Immune Response to COVID-19 and Potential Immune Modulators
Zhou, X. K., & Ye, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.646333 · Cited by 77
COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review
Trimboli, P., Cappelli, C., Croce, L., Scappaticcio, L., Chiovato, L., & Rotondi, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.707726 · Cited by 75
COVID-19 and Acute Kidney Injury
Hilton, J., Boyer, N., Nadim, M. K., Forni, L. G., & Kellum, J. A. (2022) · Critical Care Clinics · doi:10.1016/j.ccc.2022.01.002 · Cited by 81
Fujii, H., Tsuji, T., Yuba, T., Tanaka, S., Suga, Y., Matsuyama, A., Omura, A., Shiotsu, S., Takumi, C., Ono, S., et al. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05359-y · Cited by 67
Pregnancy and COVID ‐19: pharmacologic considerations
D'Souza, R. D., Ashraf, R., Rowe, H., Zipursky, J. S., Clarfield, L., Maxwell, C. V., Arzola, C., Lapinsky, S. E., Paquette, K., Murthy, S., et al. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23116 · Cited by 80
de Joode, K., Dumoulin, D. W., Tol, J., Westgeest, H. M., Beerepoot, L. V., van den Berkmortel, F. W. P. J., Mutsaers, P. G. N. J., van Diemen, N. G. J., Visser, O. J., Hoop, E. O., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.027 · Cited by 75
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
Aleissa, M. M., Silverman, E. A., Acosta, L. M. P., Nutt, C. T., Richterman, A. G., & Marty, F. M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01814-20 · Cited by 74
Strohbehn, G. W., Heiss, B. L., Rouhani, S. J., Trujillo, J., Yu, J., Kacew, A. J., Higgs, E. F., Bloodworth, J. C., Cabanov, A., Wright, R. C., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2117 · Cited by 76
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
Camprubí-Ferrer, D., Almuedo-Riera, A., Martí-Soler, H., Soriano, À., Hurtado, J. C., Subirà, C., Grau-Pujol, B., Krolewiecki, A. J., & Muñóz, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242184 · Cited by 74
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
Blot, M., Bour, J., Quenot, J., Bourredjem, A., Nguyen, M., Guy, J., Monier, S., Georges, M., Large, A., Dargent, A., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02646-9 · Cited by 75
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors
Kandasamy, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-02035-5 · Cited by 76
Glucocorticoids and the Brain after Critical Illness
Hill, A. R., & Spencer-Segal, J. L. (2021) · Endocrinology · doi:10.1210/endocr/bqaa242 · Cited by 79
Arnardottir, H. H., Pawelzik, S., Öhlund‐Wistbacka, U., Artiach, G., Hofmann, R., Reinholdsson, I., Braunschweig, F., Tornvall, P., Religa, D., & Bäck, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.624657 · Cited by 75
The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality
Ahlström, B., Frithiof, R., Hultström, M., Larsson, I., Strandberg, G., & Lipcsey, M. (2021) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13781 · Cited by 74
Gisby, J., Clarke, C., Medjeral‐Thomas, N., Malik, T. H., Papadaki, A., Mortimer, P. M., Buang, N. B., Lewis, S., Pereira, M., Toulza, F., et al. (2021) · eLife · doi:10.7554/elife.64827 · Cited by 71
Dalamaga, Μ., Christodoulatos, G. S., Karampela, Ι., Vallianou, N. G., & Apovian, C. M. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00436-y · Cited by 74
Drake, T. M., Fairfield, C. J., Pius, R., Knight, S. R., Norman, L., Girvan, M., Hardwick, H. E., Docherty, A. B., Thwaites, R. S., Openshaw, P., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00104-1 · Cited by 73
Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
Clarke, S. A., Phylactou, M., Patel, B., Mills, E., Muzi, B., Izzi‐Engbeaya, C. N., Choudhury, S., Khoo, B. C. E., Meeran, K. M., Comninos, A. N., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab349 · Cited by 74
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes
MacDonald, L., Alivernini, S., Tolusso, B., Elmesmari, A., Somma, D., Perniola, S., Paglionico, A., Petricca, L., Bosello, S. L., Carfì, A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147413 · Cited by 72
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
Rehman, M. F. U., Akhter, S., Batool, A. I., Selamoğlu, Z., Sevindik, М., Eman, R., Mustaqeem, M., Akram, M. S., Kanwal, F., Lu, C., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10081011 · Cited by 77
Neonates and COVID-19: state of the art
Ryan, L., Plötz, F. B., van den Hoogen, A., Latour, J. M., Degtyareva, M. V., Keuning, M. W., Klingenberg, C., Reiss, I. K. M., Giannoni, É., Roehr, C. C., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01875-y · Cited by 78
Bowdish, M. E., Barkauskas, C. E., Overbey, J., Gottlieb, R., Osman, K., Duggal, A., Marks, M. E., Hupf, J. C., Fernandes, E., Leshnower, B. G., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0157oc · Cited by 77
Zhang, H., Li, X., Huang, L., Gu, X., Wang, Y., Liu, M., Liu, Z., Zhang, X., Yu, Z., Wang, Y., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101668 · Cited by 79
Diabetes, obesity and COVID ‐19: A complex interplay
Vas, P. R. J., Hopkins, D., Feher, M. D., Rubino, F., & Whyte, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14134 · Cited by 75
COVID-19 -Tuberculosis interactions: When dark forces collide
Udwadia, Z., Vora, A., Tripathi, A. K. R., Malu, K. N., Lange, C. G., & Raju, R. S. (2020) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2020.07.003 · Cited by 73
Vannucchi, A. M., Sordi, B., Morettini, A., Nozzoli, C., Poggesi, L., Pieralli, F., Bartoloni, A., Atanasio, A., Miselli, F., Paoli, C., et al. (2020) · Leukemia · doi:10.1038/s41375-020-01018-y · Cited by 73
Lyngbakken, M. N., Berdal, J., Eskesen, A. N., Kvale, D., Olsen, I. C., Rueegg, C. S., Rangberg, A., Jonassen, C. M., Omland, T., Røsjø, H. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19056-6 · Cited by 75
Ranucci, M., Sitzia, C., Baryshnikova, E., Dedda, U. D., Cardani, R., Martelli, F., & Romanelli, M. M. C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113487 · Cited by 73
Izzi‐Engbeaya, C. N., Distaso, W., Amin, A., Yang, W., Idowu, O., Kenkre, J. S., Shah, R. J., Woin, E., Shi, C., Alavi, N., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001858 · Cited by 78
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
Saad, A. F., Chappell, L. C., Saade, G. R., & Pacheco, L. D. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004103 · Cited by 76
Baiou, A., Elbuzidi, A. A. S., Bakdach, D., Zaqout, A., Alarbi, K. M. S., Bintaher, A., Ali, M. M. B., Elarabi, A., Ali, G. A. M., Daghfal, J., et al. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.01.027 · Cited by 72
Xu, C., Yi, Z., Cai, R., Chen, R., Thong, B. Y., & Mu, R. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102778 · Cited by 69
Ma, S., Xu, C., Liu, S., Sun, X., Li, R., Mao, M., Feng, S., & Wang, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00521-7 · Cited by 77
Lamoth, F., Lewis, R. E., Walsh, T. J., & Kontoyiannis, D. P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab163 · Cited by 74
Distinct cytokine profiles associated with COVID-19 severity and mortality
Dorgham, K., Quentric, P., Gökkaya, M., Marot, S., Parizot, C., Sauce, D., Guihot, A., Luyt, C. E., Schmidt, M., Mayaux, J., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.047 · Cited by 78
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Klassen, S. A., Senefeld, J. W., Senese, K. A., Johnson, P. W., Wiggins, C. C., Baker, S. E., van Helmond, N., Bruno, K. A., Pirofski, L., Shoham, S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.684151 · Cited by 69
SARS-CoV-2: is there neuroinvasion?
McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 72
Scully, E. P., Schumock, G., Fu, M., Massaccesi, G., Muschelli, J., Betz, J., Klein, E. Y., West, N. E., Robinson, M., Garibaldi, B. T., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab448 · Cited by 73
Manjunath, S. H., & Thimmulappa, R. K. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.09.009 · Cited by 76
Veleri, S. (2021) · Experimental Brain Research · doi:10.1007/s00221-021-06244-z · Cited by 77
COVID-19 associated myocarditis: A systematic review
Haussner, W., DeRosa, A. P., Haussner, D., Tran, J., Torres-Lavoro, J., Kamler, J., & Shah, K. H. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.10.001 · Cited by 73
Ezer, N., Belga, S., Daneman, N., Chan, A. K., Smith, B. M., Daniels, S.-A., Moran, K., Besson, C., Smyth, L. Y., Bartlett, S. J., et al. (2021) · BMJ · doi:10.1136/bmj-2021-068060 · Cited by 73
Naendrup, J., Borrega, J. G., Eichenauer, D. A., Shimabukuro‐Vornhagen, A., Kochanek, M., & Böll, B. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211053990 · Cited by 73
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
Mao, T., Israelow, B., Lucas, C. G. D. O., Vogels, C. B. F., Gomez-Calvo, M. L., Fedorova, O., Breban, M. I., Menasché, B. L., Dong, H., Linehan, M. M., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211818 · Cited by 70
Meyer, A., Buetti, N., Houhou‐Fidouh, N., Patrier, J., Abdel-Nabey, M., Jaquet, P., Presente, S., Girard, T., Sayagh, F., Ruckly, S., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03843-8 · Cited by 75
Thomas, P., Baldwin, C. E., Beach, L. J., Bissett, B., Boden, I. J., Cruz, S. M., Gosselink, R., Granger, C. L., Hodgson, C. L., Holland, A. E., et al. (2021) · Journal of physiotherapy · doi:10.1016/j.jphys.2021.12.012 · Cited by 83
Arora, U., Priyadarshi, M., Katiyar, V., Soneja, M., Garg, P., Gupta, I., Bharadiya, V. M., Berry, P., Ghosh, T., Patel, L., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.12.039 · Cited by 74
Wagner, C., Griesel, M., Mikołajewska, A., Metzendorf, M., Fischer, A.-L., Stegemann, M. S., Spagl, M., Nair, A. A., Daniel, J., Fichtner, F., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014963.pub2 · Cited by 79
Metadata
- Authors
- The RECOVERY Collaborative Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-02-25
- Volume
- 384
- Issue
- 8
- Pages
- 693-704
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7383595
- OpenAlex
- W3042270788
- Cited by
- 11,477
- References
- 43
- Citations by year
- 2026: 301 · 2025: 573 · 2024: 932 · 2023: 1534 · 2022: 2623 · 2021: 3849
- FWCI
- 316.80
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DiRROS repository (University of Maribor) (publishedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (publishedVersion, other-oa)
- Edinburgh Napier Research Repository (Edinburgh Napier University) (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by)
- ePrints Soton (University of Southampton) (acceptedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Edinburgh Napier Research Repository (Edinburgh Napier University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Research Explorer (The University of Manchester) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- St Andrews Research Repository (St Andrews Research Repository) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- United Kingdom Research and Innovation (MC_PC_19056)
- National Institute for Health Research (MC_PC_19056)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- dexamethasone, COVID-19 pandemic, glucocorticoids, 28-day mortality, invasive mechanical ventilation, oxygen therapy, respiratory support, lung injury, anti-inflammatory therapy, hospitalized patients, RECOVERY trial, usual care comparison, treatment effect heterogeneity
- MeSH terms
- COVID-19, COVID-19 Drug Treatment, Administration, Oral, Aged, Aged, 80 and over, Anti-Infective Agents, Dexamethasone, Drug Therapy, Combination, Female, Glucocorticoids, United Kingdom, Hospitalization, Humans, Injections, Intravenous, Length of Stay, Male, Oxygen Inhalation Therapy, Respiration, Artificial, Odds Ratio, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
